Clinical and laboratory profiles of the 6 tested patients
Patients . | Laboratory criteria . | Clinical manifestations . | ||
---|---|---|---|---|
LA . | aCL . | aβ2GP1 IgG . | ||
Patient 1 | + | > 60 | + | Thromboembolism |
Patient 2 | + | > 60 | + | Arterial thrombosis |
Patient 3 | + | 36 | + | Recurrent fetal loss |
Patient 4 | − | – | + | Venous thrombosis |
Patient 5 | + | 35 | + | Venous thrombosis |
Patient 6 | − | > 60 | + | Recurrent fetal loss |
Patients . | Laboratory criteria . | Clinical manifestations . | ||
---|---|---|---|---|
LA . | aCL . | aβ2GP1 IgG . | ||
Patient 1 | + | > 60 | + | Thromboembolism |
Patient 2 | + | > 60 | + | Arterial thrombosis |
Patient 3 | + | 36 | + | Recurrent fetal loss |
Patient 4 | − | – | + | Venous thrombosis |
Patient 5 | + | 35 | + | Venous thrombosis |
Patient 6 | − | > 60 | + | Recurrent fetal loss |
LA indicates lupus anticoagulant; aCL IgG anticardiolipin antibodies (normal value < 5 IgG antiphospholipid [GPL] units); aβ2GP1 IgG, anti-β2glycoprotein 1 IgG; +, positive; −, negative.